Tuesday, August 25, 2026

South Korea Reaffirms U.S. Understanding as Jangbogo-N Nuclear Submarine Plan Moves Forward

The government addressed concerns over the 'Jangbogo N project', stating there was prior communication with the U.S. regarding nuclear submarines.

North Korea’s Nyongbyon Nuclear Facility Continues to Operate for 7th Nuclear Test

Satellite images and thermal infrared images of...

North Korea Ignores South Korea-China Summit… To Forge Ahead Until Party Congress

The government plans a meeting to discuss North Korean issues and establish a consultation channel with the U.S. Embassy.

Tag: Truxima

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How Celltrion’s Truxima Dominates the U.S. Rituximab Market: A 4-Month Winning Streak

Celltrion's Truxima leads the U.S. rituximab market for four months, gaining FDA interchangeability status, boosting growth prospects.

Celltrion’s Truxima becomes first rituximab biosimilar in U.S. to receive interchangeability designation

Celltrion's Truxima gains FDA interchangeability status, enhancing its market position and credibility in blood cancer treatment.

Truxima: How the First Korean Biosimilar Achieved 35.8% Market Share in the U.S.!

Celltrion’s Truxima becomes South Korea's first biosimilar to lead U.S. prescription market, boosted by tariff exemptions and strong growth.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.